Vimarsana
Biggest News Aggregation in the World

June Halper News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from June Halper. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In June Halper Today - Breaking & Trending Today

Top minds in multiple sclerosis to speak at CMSC 38th Annual Meeting - Vimarsana News

Top minds in multiple sclerosis to speak at CMSC 38th Annual Meeting

The leading research and educational conference for multiple sclerosis healthcare professionals in North America, the Consortium of Multiple Sclerosis Centers (CMSC) 38th Annual Meeting, returns to Nashville, Tennessee, May 29-June 1, 2024 at the Music City Center.

CMSC updates values to more actively address inequity in healthcare | CMSC addresses unequal care access that's linked to poorer MS outcomes - Vimarsana News

CMSC updates values to more actively address inequity in healthcare | CMSC addresses unequal care access that's linked to poorer MS outcomes

The Consortium of Multiple Sclerosis Centers has recently announced new initiatives to address disparities and inequality in MS care.

Neurologist Robert Lisak named 2023 Giant of Multiple Sclerosis | Award honors 10 'pioneers and leaders' in the field of MS - Vimarsana News

Neurologist Robert Lisak named 2023 Giant of Multiple Sclerosis | Award honors 10 'pioneers and leaders' in the field of MS

Neurologist Robert Lisak was named a 2023 “Giant of Multiple Sclerosis” for his work in understanding MS mechanisms and improving care.

NeurologyLive® and CMSC Announce Giants of Multiple - Vimarsana News

NeurologyLive® and CMSC Announce Giants of Multiple

CRANBURY, N.J., April 26, 2023 (GLOBE NEWSWIRE) -- NeurologyLive® and the Consortium of Multiple Sclerosis Centers (CMSC) are pleased to announce the...

TG Therapeutics Announces FDA Approval of BRIUMVI™ (ublituximab-xiiy) - Vimarsana News

TG Therapeutics Announces FDA Approval of BRIUMVI™ (ublituximab-xiiy)

TG Therapeutics Announces FDA Approval of BRIUMVI™ (ublituximab-xiiy) - read this article along with other careers information, tips and advice on BioSpace